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Abstract 
Severe Acute Respiratory Syndrome (SARS) outbreak between 2002 to 2003 has accounted for the world panic. 
SARS was caused by a novel coronavirus (SARS-CoV) and had continued to expand int the 21st century (Tsang 
et al., 2003). Initially, the disease was observed to be incepted in a small district named as Shunde, which was 
present in the city named the Foshan City of Guangdong Province. From this area, it rapidly disseminated to 
Hong Kong and following it to the rest of North America, Asia, as well as Europe in the few months. The 
disease affected about 8437 patients, accounting for a mortality rate of 9.6 percent. World Health Organization 
(WHO), in May of the year 2005, forwarded a declaration that SARS disease has been eliminated, which ranked 
it as the second disease in humans to be labeled such following the first disease, i.e., smallpox. The civet cats 
isolated coronaviruses in China has substantial sequence homology with SARS-CoV, which indicates a zoonotic 
origin.Thereby this research paper reviews the general causes of SARS, its clinical manifestation, along with its 
treatment and prevention. 
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1. Introduction 
SARS (Severe Acute Respiratory Syndrome) is a disease of respiratory virus belonging to the zoonotic origin, 
which is caused by coronavirus of SARS. During November 2002 till July 2003, an upsurge in South China of 
SARS was the reason behind the ultimate 8.098 cases, which results in the death of 774 people in 37 countries, 
with most of the cases in China (i.e., 9.6% rate of a fatality) as per the reports of WHO. There were no patients 
reported of SARS since the year 2004. In the last months of 2017, the scientists in China followed the signs of 
the viruses by the intermediary civets to cave-dwelling bats in the Province of Yunnan in China. 
SARS was a considerably unusual disease; by the end of the epidemic in the month of June 2003, there 
were 8422 patients reported with the fatality rate of 11 percent. The range of the case-fatality rate is from 0 
percent to 50 percent, which depends on the age group of the infected patient. The patients having the age below 
24 has the minimum potential to die, yet those having more than 65 are the most possibility to die. The basic 
path for the transfer of SARS is the link of the mucous membranes through the respiratory droplets or the 
fomites. While diarrhea is usual among the patients of SARS, the route of the fecal-oral is not found to be the 
usual path for the transfer. 
The main number of reproduction of SARS, R0, has a scale between 2 to 4, which is based on the various 
assessments. Control steps were announced in the month of April 2003, and this declined the rate to 0.4. The 
starting signs are similar to flu and can involve muscle pain, fever, cough, throat sore, lethargy signs, and the 
other non-particular signs. The single sign usual in all of the cases was found to be the fever more than 38°C 
(100 °F). SARS ultimately directs towards the breath shortening and pneumonia, either the active pneumonia 
through the virus of bacterial pneumonia. 
The aggregate of the incubation duration for SARS is in between 4 to 6 days, though hardly it can be as 
short as a single day or as long as 2 weeks. 
 
1.1. Problem Statement 
WHO (The World Health Organization) announced extreme acute respiratory syndrome, which contained in the 
year 2003 on 9thJuly.During these years, four patients of SARS have been registered in China between December 
2003 till January 2004. There are three special laboratories' incidents, which were the reason behind the 
infection. In a case among these, a sick lab work spread the virus to the other workers. The research of SARS 
specimens needs the BSL-3 service; some of the researches of the indirect SARS specimens may be performed at 
BSL-2 services.  
The purpose of this research is to get an in-depth knowledge of SARS. It also has an objective to observe 
the reasons and the precautions of this disorder. Thus, below are the queries inspected throughout the research, 
1. What are the basic reasons behind SARS? 
2. What are the ways for the precautions for SARS? 
3. What is the therapy of SARS? 
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2. Research Method 
There is a number of techniques that can be utilized to gather the data, and these techniques are accessible by the 
researchers, yet, the selection must be suitable and made after the analytical assessment of the targets. Therefore, 
the segment of the paper describes the techniques which are being utilized for the research and the representation 
of the evaluation segment.This segment is classified into the subheadings for the exact knowledge of technique, 
and the justification for the selection. 
 
2.1 Research Context  
A lot of methodologies can be utilized by the researchers, yet the subject of the research must highlight the 
reasoning, in line with the subject. The subject of the research in this study depends on the descriptions, which 
are linked with SARS. The reasons are majorly linked with the description and the assessment of the disease. 
The subject of the research focuses on the reasons behind the SARS, precautions, and therapy. The main aim is 
to explain the SARS in details . 
 
2.2 Research Philosophy  
A number of research ideologies are available for the researchers, such as; 
1. Ontology, 
2. Epistemology 
3. Interpretivism 
4. Positivism  
5. Axiology 
6. Realism 
This study utilizes the realist approach for the interrogation as it was most suitable in terms of representing 
the syndrome. The realist approach is the most suitable for the assessment of the reasons through the observation 
of the qualitative statements. It is now easier than ever for the researchers to enhance the awareness of this 
syndrome by this structure. The realist approach is classified into two distinguished kinds, which are direct 
realism and the analytical realism techniques, yet, it is essential that every approach must be utilized by the 
researchers for the understanding of the connections between the independent and the dependent variables. 
 
2.3 Measures  
The steps which are required to be taken by the researchers should be in line with the outcomes required to be 
attained. These steps must be taken after the proper consideration of the targets, or else, the dependency or the 
accuracy of the outcomes will be decreased. 
For the finding of the outcomes of the research, the articles which are only 10 to 15 years old will be 
utilized. This will help to collect the data through the provision of the recent trends which are assessed in the 
syndrome. Moreover, it will offer an in-depth knowledge of the disease. Another significant step for this research 
is the choice of the articles through the use of the website such as Google Scholar. The study article has an 
objective to highlight the major reason behind the syndrome, as it is significant to utilize only the study articles 
of SARS.   
 
2.4 Procedures  
This research selects a suitable process for the collection of data and the assessment to evaluate the SARS with 
the proper instructions and the realist approach. Firstly, the research questions are being determined, as it is one 
of the most significant parts of the collection of the data. Secondly, it has been examined that the questions are in 
line with the aims and targets of the study. The objectives and the questions of the research were described and 
represented by the writers to assess whether they are suitable or not. This will help to understand that if the 
targets and purpose of the study are accurate and can be relied upon or not. 
Once the study articles and the queries are being gathered, the assessment process is easier. Then the 
research articles are being gathered to conduct the desk review. Yet, before conducting the process of desk 
review, it has been confirmed that every article was in accordance with the subject. Once the statements are 
extracted from these research articles and are compared, which is a very hard step and needed that the flow must 
not be affected during the assessment of the data. After the analytical review of the reasons, it has been made 
sure that the reasons and the flow under all of the headings are in accordance with the need and the meet the 
compliance along with the research queries. 
After the analysis of the outcomes, the finalization has been performed by the researchers. Arguments for 
the writing of the descriptions and the final section is to provide the readers with a summarized form of the 
findings of the research. Thus, after the final section, it has been described in-depth, if it has everything linked 
with the research queries. With the help of the research queries, it is now easier to collect, analyze and complete 
all of the sections of this research; it is discussed again in-depth to increase the accuracy and the dependency of 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal  
Vol.64, 2020 
 
3 
the outcomes. 
 
2.5 Data Collection Method  
The research has utilized the qualitative approach to collect the data and the assessment as well. To collect the 
qualitative data, there a number of approaches that can be accessed by the researchers, for example, the 
questionnaires, the interviews, observations, and case studies. Yet, this study has utilized the qualitative 
approach to fulfill the needs of the research. The quantitative methodology is not appropriate for this research at 
the moment. 
 
2.6 Data Analysis Method  
There are different kinds of approaches available for the assessment of data and it has become essential that all 
of them must be assessed after the observation of the needs of the research for the enhancement of dependency 
and the accuracy. The approaches of the data analysis are mainly available in different kinds yet have classified 
into the quantitative and the qualitative patterns, yet, selection of the best is essential. The approach opted for the 
assessment is the desktop review approach, as this is the most appropriate method for the research. With the help 
of the various methods for the research analysis, it is now easier to assess this disease, regarding etiology, 
therapy as well as precautions. The researchers opted for the website of Google Scholar as it is found to be the 
most reliable website for the selection of the article, its evaluation as well as to compare the different articles. 
Additionally, the research article presented in the last 15 years is being considered for the review purpose. The 
review of all of the articles was performed analytically as it assisted in the analysis of the SARS in a complete 
possibility. 
 
2.7 Sample Size, Sampling Method and Population 
The size of the sample, approach and the population of the research is considered as the most significant 
framework for the observation of the analytical reviews, the approaches of the sampling are there in the different 
kinds and classified into the methods of probability sampling and non-probability sampling. This research selects 
the method of non-probability sampling as it offers the evaluation of all of the research targets in depth. Non-
probability sampling methods are available in the various formats, yet, the style which has been selected in this 
research is purposive sampling method since it will offer the evaluation of the outcomes through the observation 
of the outcomes which depends on a specific purpose. 
This sampling technique is used as it is offered in the selection of the research article dependent on the 
subject of the research. Additionally, the sample of the articles of the research was more than 20 articles for the 
analytical overview. This method of sampling helped in the selection of the most considerate articles linked with 
the subject. It also helped to understand the part of various researchers, and the arguments they include 
themselves to understand the syndrome.  
 
3 SARS in a Whole Prospective  
Thispart of the study will be discussed the followings: 
1. Main Causes,Clinical Elements, Prevalence& Control. 
2. Diagnosis 
3. Precautions or the Preventions 
4. Therapy or Treatment 
5. Prognosis 
6. Epidemiology 
 
3.1 Main Causes, Clinical Elements, Prevalence & Control. 
According to the study of Channappanavar et al. (2016), SARS causes due to the member mainly from a 
carnivorous family which can cause the common cold. From the research study, it has determined that in the year 
2003, this epidemic started by causing the virus among mammals in the Chinese economy or state. It was the 
time when mammals started with a cough and sneeze due to SARS and as results, droplets due to sneezing 
started to expand to cause further virus among people of the state. People with SARS, when coughing or sneezes 
the droplets in saliva are infectious and these droplets spray itself in the air. Thereby, another person or 
individual catches SARS. If an individual with SARS, breaths or touches to the other individuals, it spreads the 
virus to other surfaces in the form of droplets. SARS virus found on the hands including tissues and various 
other surfaces and a virus remains for several times in the form of droplets on hands and tissues of an individual. 
This virus stays for more months or even for long days when the temperature becomes below freezing.  
In addition to this, droplets go from one person to another in the form of close contact with each other as it 
had determined from various earlier cases of SARS (Channappanavar et al., 2016). In some cases, airborne 
transmission is a real possibility. The virus according to several research studies, also found in the stool of 
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various persons and it stays long for even 3 or more than three days. Symptoms of SARS remain 2 to 10 days 
after when any person contacts with SARS virus from any place or another individual. People have determined 
with active symptoms of having SARS such as illness and a person remains contagious after the symptoms 
appear. 
The study of de Wit et al. (2016), had defined SARS as the severe acute respiratory syndrome that was first 
established or discovered in Asia during the year-February 2003. This major outbreak lasted around for six 
months to spread the diseases and then it expanded in numerous countries including; South and North America, 
Europe etc. The study of de Wit et al. (2016), had defined the guidelines published by the Centers for Disease 
Control and Prevention (CDC), as according to the guidelines of Centers for Disease Control and Prevention 
(CDC), lab test is crucial to detect SARS virus because it includes in the blood of an individual or urine, stool 
tests are also necessary to determine the presence of SARS. According to the study of Channappanavar et al. 
(2016), there is no proper control to SARS virus but from the research, it has analyzed that various vaccines are 
behaving as the cure to prevent further risk of SARS. People with SARS should be admitted to hospitals 
immediately under the closest observation and supportive treatment is necessary which also includes; ventilator 
to provide oxygen to an individual. 
The study of Menachery et al. (2016), had defined that several complications occur when a person is 
diagnosed with SARS. These complications include; having pneumonia, breathing problem due to which person 
needs oxygen or ventilator. In addition to this, illness due to SARS is fatal in some major cases significantly due 
to respiratory failure. Other complications due to SARS include heart and liver failure. People who are of 60 or 
more than 60 age, particularly those people who have diabetes and hepatitis are at the highest risk of vulnerable 
complexities or complications due to SARS (de Wit et al., 2016; Yang et al., 2017). 
 
3.2 Diagnosis 
The recent WHO identification of SARS needs the description of the clinical characteristics (fever ≧38 C, 
symptoms of respiration, radiographic pneumonia, and autopsy outcomes of persistent pathology in otherwise 
undefines illness) and in the existence of the virological evidence of SARS-CoV infection (which is positive RT-
PCR for the existence of SARS-CoV RNA, seroconversion with particular antibody emerged in paired sera or 
virus isolation). In a practical manner, the prerequisite for the detection of SARS involve the existence of an 
epidemiological connection, instantly growing pneumonia repellent to standard therapy, clinical characteristics, 
and virological proof of SARS-CoV infection. An epidemiological connection, described as a background of 
contact with a SARS patient or visiting a hospital with nosocomial SARS outbreak, in the 10 days preceding 
disease onset, is helpful for the infected patients in regions of upsurge. Virtually all of the patients decline 
irrespective of the potent antibiotic therapy (Tsang et al., 2003), and main have lymphopenia and emerging 
transaminase standards. 
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A chest X-ray representing enhanced opacity in both lungs, detecting the pneumonia, in a SARS patient. 
SARS can be doubtful in a patient having: 
 Any of the signs, which includes 38 °C (100 °F) or more fever, and 
 Have a background of: 
1. Link (sexual or casual) with anyone who has diagnosed SARS in the last 10 days or 
2. Visit any of the areas highlighted by the World Health Organization (WHO) as the region with current 
domestic transfer of SARS. 
For a situation to be found as a possibility, an X-ray of chest should be positive for atypical 
pneumonia or respiratory distress syndrome. 
It has been defined by WHO that the class of "laboratory confirmed SARS" for the possible patients yet do not 
have a positive chest X-ray changes, but they have been tested positive for SARS depending on one of the 
acknowledged tests (ELISA, immunofluorescence or PCR).  
The emergence of SARS in chest X-rays is not the same yet normally emerge as an abnormal patch of infiltrates.  
 
3.3 Prevention 
SARS has no vaccine. Quarantine and isolation are the basic successful methods effective for the prevention of 
the growth of SARS. Other steps for the prevention include: 
 To wash hand 
 To disinfect the areas for fomites 
 Wear a mask of surgical 
 Avoid the bodily fluids’ contact  
 Wash the private material of SARS patient in hot, soapy water (which includes utensils and dishes for 
eating, bedding, etc.)  
 Keep children with signs home from school 
 Usual hygiene steps 
 Isolate oneself to the maximum for the reduction of chances of transfer of virus 
 
3.4 Treatment  
The therapy for SARS, managed during the catastrophic conditions of 2003, were highly unsystematic and was 
not backed up by the monitored trial information.   
3.4.1 Pharmacotherapy of SARS 
Conceptually, there will be no indication of SARS if the effective antivirus agents are given to the disorder 
onset. Yet, the agents with proven effectiveness cannot be accessed despite the productive recommendations. 
Other than managerial treatment of the empirical antibiotics for the extreme community gained pneumonia, it is 
suggested to monitor the clinics to assess the effectiveness of the possible immunomodulating and antivirus 
agents. The clinical sufferings can be accessed by some agents utilized in 2003 upsurge, which are named as 
corticosteroids, convalescence serum, interferons, ritonavir/lopinavir, ribavirin, and immunoglobulin. In the past 
years, and before WHO described SARS, the infected individuals were being healed and cured with the wide-
spectrum agent of antivirus, which named as corticosteroid and ribavirin. Almost 60 percent of hemoglobin of 
the patients declined by 2 g/dl after the therapy with ribavirin (1.2 g tid) for 14 days, and a greater amount of the 
dose was linked with the increased range of liver transaminase and bradycardia (Booth et al., 2003). The instant 
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cure of some of the first patients in Hong Kong has given a direction to adopt the mentioned as the benchmark 
antiSARS regimen in the year 2003 in Hong Kong and the other countries as well. Ribavirin is now found to be 
failed. The effectiveness of the other potential agents of anti-SARS-CoV for example antiproteases such as 
Kaletra (lopinavir 100 mg and ritonavir 400 mg for two weeks), with the integration of ribavirin as the starting 
therapy, was linked with the decline of mortality rate (2.3 percent versus 15.6 percent) and in the rate of 
intubation from 0 percent versus 11 percent when they are being contrasted with the past monitoring (Chu et al., 
2004).Thus it has been observed that lopinavir/ ritonavir can be used for the starting therapy of the patients 
infected with SARS, preferably in an arrangement which is monitored examination.Unfavorable responses are 
frequent and involve extreme diarrhea, abdominal pain, headache, skin rash, insomnia, nausea, asthenia, and 
pancreatitis.  
Interferon a-n3, a-n1, and b-1b and the human leukocyte interferon show overall cytopathic impacts of 
SARS-CoV in vitro. Patients of SARS who are cured with interferon alfacon-1 and corticosteroids have a lower 
rate for admission to ICU, mechanical ventilation, and death (Loutfy et al., 2003). SARS-CoV is a wrapped 
RNA virus that contains various structured proteins. Recently, various doses, for example, the total killed dose, a 
vaccine for the adenovirus vector, and the protein dose with the recombinant spike are being examined among 
the animals in the labs, but these are not prepared for the large clinical examinations. 
3.4.2Immunomodulating Agents 
Management of corticosteroids for the deterioration of the SARS patients is linked with importance, and some of 
the times, drastic clinical and radiographic healings (Figure 1). Rather than skepticism, the immunomodulating 
drugs can be used for the rescue treatments. Patients who are suffering from pulse steroid therapy (such as 
methylprednisolone 250 to 500 mg daily for 3 to 5 days) did not have greater cumulative steroid dose or negative 
impacts, yet had less need if the oxygen and improved result of radiography, than their matches counterparts (Ho 
et al., 2003). Though a retrospective assessment represented a greater 30-day mortality rate among the patients 
having pulse methylprednisolone, this can be due to the greater possibility of utilizing this treatment in many 
extreme SARS patients. Corticosteroids are successful agents of anti-inflammatory, which remarkably decrease 
the rates of IFN-g inducible protein- 10, monocyte chemoattractant protein-1 and interleukin-8 in SARS (Wong 
et al., 2004). The usage of higher doses of steroids was linked with sepsis, specifically ventilator-connected 
pneumonia, and even the structured infection of fungus. Almost 15 percent of the patients of SARS had MRI-
proven avascular necrosis (AVN) of knees and hips (Griffith et al., 2005).  
3.4.3 Miscellaneous Agents 
Convalescence serum was managed to 19 patients of SARS in Hong Kong in the year 2003, and receivers had a 
smaller stay in the hospitals and lesser rate mortality than their matches (Soo et al., 2004). The potential transfer 
of SARS-CoV (and other pathogens), conceptual drawbacks of its pro-inflammatory activities, and the recent 
lack make this way of the possible treatment disagreeable. Several other agents are being recommended to be 
possibly effective for SARS, by the benefit of their in vitro or only in conceptual actions contrary to SARS-CoV. 
These involve synthetic RNA duplexes, glycyrrhizin (licorice extract) which targets both SARS-CoV genomes, 
heparin and antiplateletagents,  nelfinavir, niclosamide, rhinovirus 3C proinhibitor analogs, anti-tumor necrosis 
factor-a, aminopeptidase N inhibitor, sodium nitroprusside, and a monoclonal antibody against S1 protein (Tsang 
et al., 2004).  
3.4.4 Noninvasive Positive Pressure Ventilation (Nippv) 
Almost 20 percent of the patients of SARS grown the syndrome of acute respiratory distress, which needs 
invasive mechanical ventilation linked with the nosocomial growth of SARS. Yet, NIPPV utilization among the 
SARS cases in Hong Kong was observed to be successful for the prevention of intubation and oxygenation, with 
no proof of nosocomial growth of SARS (Cheung et al., 2004). 
Antibiotics have been failed since SARS is a viral disease. The cure of SARS is majorly helpful with the 
antipyretics, mechanical ventilation, and the supplementary oxygen as per the requirements. The medicines for 
the antivirus are being utilized along with the higher dosage of steroids to decrease the swelling of the lungs. 
SARS patients should be isolated, in the rooms having negative pressure, with the total precautions of nursing 
taken for the essential connection with the patients, for the limitation of the possibilities of medical individuals to 
get infected with SARS. As in the year 2017, there is no therapy or the protective dose for SARS, which has 
been presented to both secure and successful among humans. The discovery and the growth of the new doses and 
the drugs to cure SARS is a preference of the government and the bodies of public health all over the globe. 
MassBiologics, which is an NPO (a non-profit organization) involved to identify, grow and produce the organic 
treatments, is integrating with scientists at NIH and the CDC to develop a monoclonal antibody treatment, which 
defines the effectiveness in the models of animals.  
 
3.5 Prognosis  
The aggregate time for the stay in hospital was 21 days for the majority of the patients in the year 2003 in Hong 
Kong, and the 21-day mortality rate ranges from 3.6 to 10 percent. The last patient fatality ratio for Hong Kong, 
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as well as Canada, was found to be17 percent, because of greater mortality among the patients having bad 
projections. Bad prognostic characteristics anticipation of death or admission in ICU involved higher age, 
diabetes mellitus or other comorbid conditions, chronic hepatitis B cured with lamivudine, high serum lactate 
dehydrogenase, and high rate of neutrophil, and low rate of CD4 and CD8 lymphocyte.  
Various finalized reports in China regarding the patients who recovered from SARS showed extreme long 
term sequelae. The typical basic disorders are osteoporosis, femoral necrosis, and pulmonary fibrosis, which 
have given a direction towards overall loss of working capability or capability of self-care.  
 
3.6 pidemiology and Infection Control 
SARS was a considerably unusual disease; by the end of the epidemic in June of the year 2003, the accident was 
8422 patients having the rate of case-fatality of 11 percent.  
The range of the case-fatality ratio is from 0 percent to 50 percent based on the age of the patient. Patients 
have age less than 24 years had the least possibility to die, and the patients have age more than 65 years and 
older had the most possibility to die.  
The most significant standard for SARS is to make sure no more upsurge in the hospitals as well as society. 
Isolated nursing can be obtained in either the single rooms or even in the open wards, as long as they are 
completely managed and monitored. The rate of air exchange of 12 times per hour and a temperature of 20 C is 
found to be the requirement since the wearing of personal protective equipment (PPE) by the workers can be hot. 
Personal protective equipment must be offered to the trained workers involving the usage of gowns covering 
full-body and particular masks (for example, N95 masks). All of the workers are needed to obey rigid and 
systematic ‘gowning’ and ‘degowning’ processes. Precise individual cleanliness is needed. Diluted bleach is 
being utilized to clean all surfaces as well as the floor after an hour or after any possible impurity. As nebulizer 
treatment was supposed to be the reason for the most upsurge in the hospital of Hong Kong, this way of 
treatment is prohibited for patients with doubtful or possible SARS in Hong Kong. 
 
Conclusion 
The study has defined the pharmacotherapy of severe acute respiratory syndrome (SARS), it has defined the 
cause, prevention, prevalence and control of severe acute respiratory syndrome. It has briefly defined the 
immunomodulating agents concerning SARS and the other miscellaneous agents. It had also explained the 
noninvasive pressure ventilation (Nippv). From the overall discussion, it concludes that the control on SARS 
might be possible but in some casesit causes vulnerable deaths and complications to individuals. Complications 
like heart and liver failure.  
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